For the year ending 2025-12-31, TER had -$259,603K decrease in cash & cash equivalents over the period. $450,406K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 554,047 | 542,372 | 448,752 | 715,501 |
| Depreciation | 111,445 | 100,977 | 92,118 | 90,763 |
| Stock-based compensation | 63,999 | 60,122 | 57,682 | 48,228 |
| Equity in net earnings of affiliate | -19,914 | -7,211 | - | - |
| Losses (gains) on investments | 5,420 | -10,056 | 14,915 | -9,985 |
| Provision for excess and obsolete inventory | 25,782 | 18,922 | 28,358 | 31,452 |
| Amortization | 16,536 | 18,764 | 18,768 | 19,912 |
| Loss (gain) on sale of business | 0 | 57,119 | - | - |
| Gains on sale of asset | - | - | 0 | 3,410 |
| Deferred taxes | -52,067 | -46,360 | -37,642 | -38,693 |
| Loss on convertible debt conversion | - | - | 0 | 0 |
| Retirement plan actuarial losses (gains) | -683 | 4,355 | -2,703 | 25,584 |
| Contingent consideration adjustment | - | - | 0 | 0 |
| Loss (gain) on sale of asset | - | 0 | - | - |
| Other | -12,005 | 2,290 | 955 | -2,353 |
| Accounts receivable | 305,601 | 52,659 | -70,977 | -50,628 |
| Inventories | 28,424 | -8,707 | -5,327 | 80,809 |
| Prepayments and other assets | 6,591 | -119,454 | 43,101 | 140,713 |
| Accounts payable and other liabilities | 208,848 | -54,386 | 46,782 | -60,507 |
| Deferred revenue and customer advances | 52,626 | 12,176 | -57,210 | -6,233 |
| Retirement plans contributions | -8,483 | -5,814 | -5,492 | -5,116 |
| Income taxes | 15,116 | -3,602 | -26,921 | -29,834 |
| Net cash provided by operating activities | 674,415 | 672,176 | 585,231 | 577,923 |
| Proceeds from sale of asset | - | 0 | 0 | 3,410 |
| Purchases of property, plant and equipment | 224,009 | 198,095 | 159,642 | 163,249 |
| Acquisition of businesses, net of cash and cash equivalents acquired | 144,380 | - | 0 | 0 |
| Purchase of investment in a business | 25,519 | 532,060 | - | - |
| Purchases of marketable securities | 32,999 | 45,796 | 161,906 | 287,409 |
| Issuance of convertible loan | 0 | 0 | 5,000 | - |
| Proceeds from the sale of a business, net of cash and cash equivalents sold | 0 | 90,348 | - | - |
| Proceeds from maturities of marketable securities | 48,951 | 38,353 | 85,042 | 222,941 |
| Proceeds from sales of marketable securities | 9,339 | 24,035 | 61,401 | 268,058 |
| Proceeds from insurance | 0 | -873 | -460 | 0 |
| Net cash used for investing activities | -368,617 | -622,342 | -179,645 | 43,751 |
| Proceeds from borrowings on revolving credit facility | 250,000 | 185,000 | - | - |
| Repayments of borrowings on revolving credit facility | 50,000 | 185,000 | - | - |
| Dividend payments | 76,313 | 76,423 | 67,878 | 69,711 |
| Repurchase of common stock | 702,095 | 198,574 | 397,241 | 752,082 |
| Payments related to net settlement of employee stock compensation awards | 15,702 | 14,100 | 20,788 | 33,170 |
| Payments of convertible debt principal | 0 | 0 | 50,264 | 66,759 |
| Issuance of common stock under stock purchase and stock option plans | 31,860 | 37,330 | 34,259 | 28,733 |
| Payments of contingent consideration | - | - | - | 0 |
| Net cash used for financing activities | -562,250 | -251,767 | -501,912 | -892,989 |
| Effects of exchange rate changes on cash and cash equivalents | -3,151 | -2,284 | -876 | 3,889 |
| Decrease increase in cash and cash equivalents | -259,603 | -204,217 | -97,202 | -267,426 |
| Cash and cash equivalents at beginning of year | 553,354 | 757,571 | 854,773 | - |
| Cash and cash equivalents at end of year | 293,751 | 553,354 | 757,571 | - |
TERADYNE, INC (TER)
TERADYNE, INC (TER)